ADC Therapeutics SA (NYSE:ADCT)

2.28
Delayed Data
As of May 26
 -0.03 / -1.30%
Today’s Change
1.85
Today|||52-Week Range
10.88
-40.62%
Year-to-Date
No recent news for ADC Therapeutics SA.

Today’s Trading

Previous close2.31
Today’s open2.32
Day’s range2.27 - 2.32
Volume232,306
Average volume (3 months)529,514
Market cap$183.9M
Data as of 3:59pm ET, 05/26/2023

Growth & Valuation

Earnings growth (last year)+33.49%
Earnings growth (this year)-30.73%
Earnings growth (next 5 years)+16.95%
Revenue growth (last year)+518.89%
P/E ratioNM
Price/Sales1.43
Price/Book2.07

Competitors

No competitors data available.

Financials

Next reporting dateAugust 22, 2023
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$209.9M
Annual profit (last year)-$155.8M
Net profit margin-74.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --

Forecasts